Pharming Group Ownership

PHGUF Stock  USD 0.75  0.00  0.00%   
Pharming Group owns a total of 652.41 Million outstanding shares. Roughly 81.6 pct. of Pharming Group outstanding shares are held by general public with 1.97 % owned by insiders and only 16.43 (%) by third-party entities. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in pink sheets such as Pharming Group in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Pharming Group, and when they decide to sell, the pink sheet will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pharming Group NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.

Pharming Pink Sheet Ownership Analysis

About 16.0% of the company shares are owned by institutional investors. The book value of Pharming Group was at this time reported as 0.3. The company had not issued any dividends in recent years. Pharming Group NV had 1:10 split on the 5th of March 2013. Pharming Group N.V., a biopharmaceutical company, develops and commercialize protein replacement therapies and precision medicines for the treatment of rare diseases and unmet medical needs in the United States, Europe, and internationally. Pharming Group N.V. is headquartered in Leiden, the Netherlands. Pharming Grp operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 277 people.The quote for Pharming Group NV is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Pharming Group NV contact MBA MD at 31 71 524 7400 or learn more at https://www.pharming.com.

Currently Active Assets on Macroaxis

Additional Information and Resources on Investing in Pharming Pink Sheet

When determining whether Pharming Group NV is a strong investment it is important to analyze Pharming Group's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Pharming Group's future performance. For an informed investment choice regarding Pharming Pink Sheet, refer to the following important reports:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pharming Group NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.
You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Please note, there is a significant difference between Pharming Group's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pharming Group is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pharming Group's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.